Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp393 | Osteoporosis: treatment | ECTS2013

Remarkable bone mineral density increases on teriparatide in patients with glucocorticoid-induced osteoporosis and Crohn's disease

Ko-Wu Kuo Danny , To Kenny , Kendler David

Crohn’s disease often results in abnormalities in bone strength, and ultimately increases the risk of fragility fracture. Up to 55% of patients with Crohn’s disease have bone mineral density in the osteopenia range up to 50% of osteoporosis. Glucocorticoid is frequently used in the treatment of Crohn’s disease and is associated with osteoporosis and increased fracture risk. It has been reported that osteoporotic fractures in patients with Crohn’s disease ar...

ba0006p161 | (1) | ICCBH2017

Early-life vitamin D status and bone mass at five years in a prospective birth cohort study

Chaoimh Carol ni , Murray Deirdre , Kenny Louise , Irvine Alan , Hourihane Jonathan , Kiely Mairead

Objective: We aimed to investigate associations between early-life vitamin D status, mode of infant milk-feeding and bone outcomes at five years.Methods: Participants were from the prospective mother-infant SCOPE-BASELINE Birth Cohort Study. Serum 25 hydroxyvitamin D (25(OH)D) concentrations were quantified at 15 weeks gestation, in umbilical cord sera and at two and five years using a gold-standard CDC-accredited LCMS method. Whole-body bone mineral con...